Skip to main content

Table 1 Patient characteristics

From: Total metabolic lesion volume of lymph nodes measured by 18F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still’s disease

Demographics

 Number

57

 Age (y)

34 (26–47)

 Female

48/9

 Disease duration (months)

3 (1–12)

Clinical features

 Fever > 39 °C

46 (80.7)

 Skin rash

52 (91.2)

 Arthralgia

52 (91.2)

 Sore throat

44 (77.2)

 Lymphadenopathy

43 (75.4)

 Splenomegaly

25 (43.9)

 Hepatomegaly

9 (15.8)

 Pleuritis

20 (35.1)

 Pericarditis

14 (24.6)

 Weight loss

14 (24.6)

 Lung disease

1 (1.8)

Laboratory findings

 Leukocytosis (> 10,000/mm3)

34 (59.7)

 Neutrophils (> 80%)

36 (63.2)

 Hb < 90 g/L

9 (15.8)

 PLT < 100,000/mm3

2 (3.5)

 ESR > 40 mm/h

42 (73.7)

 CRP > ULN

54 (94.7)

 Serum ferritin > 5 ULN

36 (63.2)

 Abnormal liver function

36 (63.2)

 Negative ANA (titer ≤ 1:80)

54 (94.7)

 Negative RF

56 (98.2)

 IL2R > ULN

33/45 (73.3)

 Pouchot score

7 (5–7.5)

  1. Data are presented in the form of median (Q1–Q3) as continuous variable or as absolute number (percentage of the total patients%);
  2. ULN upper limit of normal, Hb hemoglobin, PLT platelet, ESR erythrocyte sedimentation rate, ANA antinuclear antibody, RF rheumatoid factor, CRP C-reactive protein, IL-2R interleukin-2 receptor